The dilemma of whether to continue TNFα blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ

Louise Zuzarte, Sara Mirhadi, Richard A Carr, Simon Tso
2019 BMJ Case Reports  
doi:10.1136/bcr-2019-232536 pmid:31732538 pmcid:PMC6887357 fatcat:qn6n3ty6fzcllakwq3ne24at7q